Betta Pharmaceuticals and Shengsi Biotech have reached a strategic cooperation and obtained exclusive distribution rights for the FRSW117 product in the Greater China region
Afternoon of the third day of the 2025 National Conference: Representatives from companies such as Novartis, Roche, and Betta Pharmaceuticals enter
BETTA PHARMACEUTICALS: The company currently does not have exclusive agency for foreign products
New Stock News | Betta Pharmaceuticals has submitted its application to the Hong Kong Stock Exchange and has successfully transformed into a "platform-based pharmaceutical company."
Beijing Beida Pharmaceutical Co., Ltd. submitted a listing application to the Hong Kong Stock Exchange
BETTA PHARMACEUTICALS: Will strive for more new drug approvals in high-incidence tumor areas such as lung cancer and breast cancer